Cardiomyopathy

In study, genetic testing catches missed cardiac diagnoses
Researchers at Northwestern University and colleagues reported that in their cohort study of 4,782 patients with a suspected genetic cardiomyopathy or arrhythmia, the combined testing approach captured nearly 11% of patients whose diagnosis would have been missed if genetic testing had been limited to a specific suspected disease.
August 24, 2022
2022 08 25 13 55 6515 Heart Health Stethoscope 400
Heart association offers advice on who should get genetic testing
Published on July 13 in Circulation: Genomic and Precision Medicine, the statement provides information on what the scientific community does and doesn't know about genes and genetic combinations that may influence heritable heart disease risk.
July 23, 2020
2019 11 15 19 27 0360 Heart Scan 400
Diagnomics debuts cardiovascular health panel
The Gene Impetus - Cardiac Care report will tap into information on more than 110 genes underlying more than 30 cardiovascular conditions, such as cardiomyopathies, high cholesterol, and arrythmias, according to the company.
October 7, 2019
2019 04 19 17 18 7022 Dna Strand 400
Invitae provides free testing to pancreatic cancer patients
Patients must meet criteria in specific clinical areas where genetic testing is underutilized to be eligible for testing. Professional guidelines recommend genetic testing for all pancreatic cancer patients to guide treatment choices and evaluate eligibility for clinical trials, the company noted in a statement.
September 8, 2019
2019 07 04 00 23 3413 Pancreas New 400
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Page 1 of 1